Sanguinarine Induces Necroptosis of HCC by Targeting PKM2 Mediated Energy Metabolism.
Title: | Sanguinarine Induces Necroptosis of HCC by Targeting PKM2 Mediated Energy Metabolism. |
---|---|
Authors: | Kong, Rui1 (AUTHOR), Wang, Nan2,3 (AUTHOR) wanrong1970@163.com, Zhou, Chunli1 (AUTHOR), Zhou, Yuqing1 (AUTHOR), Guo, Xiaoyan4 (AUTHOR), Wang, Dongyan4 (AUTHOR), Shi, Yihai4 (AUTHOR), Wan, Rong3 (AUTHOR), Zheng, Yuejuan5 (AUTHOR) zhengyj@shutcm.edu.cn, Lu, Jie3,4 (AUTHOR) zhengyj@shutcm.edu.cn |
Source: | Cancers. Jul2024, Vol. 16 Issue 14, p2533. 19p. |
Subject Terms: | *COMPUTER-assisted molecular modeling, *BIOLOGICAL models, *FLOW cytometry, *IN vitro studies, *TISSUE arrays, *RESEARCH funding, *COLONY-forming units assay, *GLYCOLYSIS, *PHOSPHORYLATION, *MITOCHONDRIA, *T-test (Statistics), *DATA analysis, *HOMEOSTASIS, *ANTINEOPLASTIC agents, *ELECTRON microscopy, *APOPTOSIS, *CELL proliferation, *PHYTOCHEMICALS, *TUMOR markers, *CYTOSKELETAL proteins, *CELLULAR signal transduction, *REVERSE transcriptase polymerase chain reaction, *DESCRIPTIVE statistics, *IN vivo studies, *FLUORESCENT antibody technique, *ENERGY metabolism, *CELL lines, *MICE, *METASTASIS, *REACTIVE oxygen species, *IMMUNOHISTOCHEMISTRY, *CELL death, *ANIMAL experimentation, *WESTERN immunoblotting, *GENE expression profiling, *ONE-way analysis of variance, *STATISTICS, *MOLECULAR structure, *STAINS & staining (Microscopy), *DATA analysis software, *HEPATOCELLULAR carcinoma, *SEQUENCE analysis, *PRECIPITIN tests, *PHARMACODYNAMICS |
Abstract: | Simple Summary: Here, we show that the plant-derived product, sanguinarine, inhibited aerobic glycolysis and oxidative phosphorylation; which resulted in energy alternations and necroptosis of tumor cells. Moreover, we identify the PKM2/β-catenin axis as the main target in sanguinarine treatment against HCC development. Backgrounds: Abnormal metabolism is the hallmark of hepatocellular carcinoma. Targeting energy metabolism has become the major focus of cancer therapy. The natural product, sanguinarine, displays remarkable anti-tumor properties by disturbing energy homeostasis; however, the underlying mechanism has not yet been elucidated. Methods: The anticancer activity of sanguinarine was determined using CCK-8 and colony formation assay. Morphological changes of induced cell death were observed under electron microscopy. Necroptosis and apoptosis related markers were detected using western blotting. PKM2 was identified as the target by transcriptome sequencing. Molecular docking assay was used to evaluate the binding affinity of sanguinarine to the PKM2 molecule. Furthermore, Alb-CreERT2; PKM2loxp/loxp; Rosa26RFP mice was used to construct the model of HCC—through the intervention of sanguinarine in vitro and in vivo—to accurately explore the regulation effect of sanguinarine on cancer energy metabolism. Results: Sanguinarine inhibited tumor proliferation, metastasis and induced two modes of cell death. Molecular docking of sanguinarine with PKM2 showed appreciable binding affinity. PKM2 kinase activity and aerobic glycolysis rate declined, and mitochondrial oxidative phosphorylation was inhibited by sanguinarine application; these changes result in energy deficits and lead to necroptosis. Additionally, sanguinarine treatment prevents the translocation of PKM2 into the nucleus and suppresses the interaction of PKM2 with β-catenin; the transcriptional activity of PKM2/β-catenin signaling and its downstream genes were decreased. Conclusions: Sanguinarine showed remarkable anti-HCC activity via regulating energy metabolism by PKM2/β-catenin signaling. On the basis of these investigations, we propose that sanguinarine might be considered as a promising compound for discovery of anti-HCC drugs. [ABSTRACT FROM AUTHOR] |
Copyright of Cancers is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
Database: | Academic Search Complete |
Full text is not displayed to guests. | Login for full access. |
FullText | Links: – Type: pdflink Text: Availability: 1 CustomLinks: – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:a9h&genre=article&issn=20726694&ISBN=&volume=16&issue=14&date=20240715&spage=2533&pages=2533-2551&title=Cancers&atitle=Sanguinarine%20Induces%20Necroptosis%20of%20HCC%20by%20Targeting%20PKM2%20Mediated%20Energy%20Metabolism.&aulast=Kong%2C%20Rui&id=DOI:10.3390/cancers16142533 Name: Full Text Finder (for New FTF UI) (s8985755) Category: fullText Text: Find It @ SCU Libraries MouseOverText: Find It @ SCU Libraries |
---|---|
Header | DbId: a9h DbLabel: Academic Search Complete An: 178701175 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
IllustrationInfo | |
Items | – Name: Title Label: Title Group: Ti Data: Sanguinarine Induces Necroptosis of HCC by Targeting PKM2 Mediated Energy Metabolism. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Kong%2C+Rui%22">Kong, Rui</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Nan%22">Wang, Nan</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<i> wanrong1970@163.com</i><br /><searchLink fieldCode="AR" term="%22Zhou%2C+Chunli%22">Zhou, Chunli</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhou%2C+Yuqing%22">Zhou, Yuqing</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Guo%2C+Xiaoyan%22">Guo, Xiaoyan</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wang%2C+Dongyan%22">Wang, Dongyan</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Shi%2C+Yihai%22">Shi, Yihai</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wan%2C+Rong%22">Wan, Rong</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zheng%2C+Yuejuan%22">Zheng, Yuejuan</searchLink><relatesTo>5</relatesTo> (AUTHOR)<i> zhengyj@shutcm.edu.cn</i><br /><searchLink fieldCode="AR" term="%22Lu%2C+Jie%22">Lu, Jie</searchLink><relatesTo>3,4</relatesTo> (AUTHOR)<i> zhengyj@shutcm.edu.cn</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Cancers%22">Cancers</searchLink>. Jul2024, Vol. 16 Issue 14, p2533. 19p. – Name: Subject Label: Subject Terms Group: Su Data: *<searchLink fieldCode="DE" term="%22COMPUTER-assisted+molecular+modeling%22">COMPUTER-assisted molecular modeling</searchLink><br />*<searchLink fieldCode="DE" term="%22BIOLOGICAL+models%22">BIOLOGICAL models</searchLink><br />*<searchLink fieldCode="DE" term="%22FLOW+cytometry%22">FLOW cytometry</searchLink><br />*<searchLink fieldCode="DE" term="%22IN+vitro+studies%22">IN vitro studies</searchLink><br />*<searchLink fieldCode="DE" term="%22TISSUE+arrays%22">TISSUE arrays</searchLink><br />*<searchLink fieldCode="DE" term="%22RESEARCH+funding%22">RESEARCH funding</searchLink><br />*<searchLink fieldCode="DE" term="%22COLONY-forming+units+assay%22">COLONY-forming units assay</searchLink><br />*<searchLink fieldCode="DE" term="%22GLYCOLYSIS%22">GLYCOLYSIS</searchLink><br />*<searchLink fieldCode="DE" term="%22PHOSPHORYLATION%22">PHOSPHORYLATION</searchLink><br />*<searchLink fieldCode="DE" term="%22MITOCHONDRIA%22">MITOCHONDRIA</searchLink><br />*<searchLink fieldCode="DE" term="%22T-test+%28Statistics%29%22">T-test (Statistics)</searchLink><br />*<searchLink fieldCode="DE" term="%22DATA+analysis%22">DATA analysis</searchLink><br />*<searchLink fieldCode="DE" term="%22HOMEOSTASIS%22">HOMEOSTASIS</searchLink><br />*<searchLink fieldCode="DE" term="%22ANTINEOPLASTIC+agents%22">ANTINEOPLASTIC agents</searchLink><br />*<searchLink fieldCode="DE" term="%22ELECTRON+microscopy%22">ELECTRON microscopy</searchLink><br />*<searchLink fieldCode="DE" term="%22APOPTOSIS%22">APOPTOSIS</searchLink><br />*<searchLink fieldCode="DE" term="%22CELL+proliferation%22">CELL proliferation</searchLink><br />*<searchLink fieldCode="DE" term="%22PHYTOCHEMICALS%22">PHYTOCHEMICALS</searchLink><br />*<searchLink fieldCode="DE" term="%22TUMOR+markers%22">TUMOR markers</searchLink><br />*<searchLink fieldCode="DE" term="%22CYTOSKELETAL+proteins%22">CYTOSKELETAL proteins</searchLink><br />*<searchLink fieldCode="DE" term="%22CELLULAR+signal+transduction%22">CELLULAR signal transduction</searchLink><br />*<searchLink fieldCode="DE" term="%22REVERSE+transcriptase+polymerase+chain+reaction%22">REVERSE transcriptase polymerase chain reaction</searchLink><br />*<searchLink fieldCode="DE" term="%22DESCRIPTIVE+statistics%22">DESCRIPTIVE statistics</searchLink><br />*<searchLink fieldCode="DE" term="%22IN+vivo+studies%22">IN vivo studies</searchLink><br />*<searchLink fieldCode="DE" term="%22FLUORESCENT+antibody+technique%22">FLUORESCENT antibody technique</searchLink><br />*<searchLink fieldCode="DE" term="%22ENERGY+metabolism%22">ENERGY metabolism</searchLink><br />*<searchLink fieldCode="DE" term="%22CELL+lines%22">CELL lines</searchLink><br />*<searchLink fieldCode="DE" term="%22MICE%22">MICE</searchLink><br />*<searchLink fieldCode="DE" term="%22METASTASIS%22">METASTASIS</searchLink><br />*<searchLink fieldCode="DE" term="%22REACTIVE+oxygen+species%22">REACTIVE oxygen species</searchLink><br />*<searchLink fieldCode="DE" term="%22IMMUNOHISTOCHEMISTRY%22">IMMUNOHISTOCHEMISTRY</searchLink><br />*<searchLink fieldCode="DE" term="%22CELL+death%22">CELL death</searchLink><br />*<searchLink fieldCode="DE" term="%22ANIMAL+experimentation%22">ANIMAL experimentation</searchLink><br />*<searchLink fieldCode="DE" term="%22WESTERN+immunoblotting%22">WESTERN immunoblotting</searchLink><br />*<searchLink fieldCode="DE" term="%22GENE+expression+profiling%22">GENE expression profiling</searchLink><br />*<searchLink fieldCode="DE" term="%22ONE-way+analysis+of+variance%22">ONE-way analysis of variance</searchLink><br />*<searchLink fieldCode="DE" term="%22STATISTICS%22">STATISTICS</searchLink><br />*<searchLink fieldCode="DE" term="%22MOLECULAR+structure%22">MOLECULAR structure</searchLink><br />*<searchLink fieldCode="DE" term="%22STAINS+%26+staining+%28Microscopy%29%22">STAINS & staining (Microscopy)</searchLink><br />*<searchLink fieldCode="DE" term="%22DATA+analysis+software%22">DATA analysis software</searchLink><br />*<searchLink fieldCode="DE" term="%22HEPATOCELLULAR+carcinoma%22">HEPATOCELLULAR carcinoma</searchLink><br />*<searchLink fieldCode="DE" term="%22SEQUENCE+analysis%22">SEQUENCE analysis</searchLink><br />*<searchLink fieldCode="DE" term="%22PRECIPITIN+tests%22">PRECIPITIN tests</searchLink><br />*<searchLink fieldCode="DE" term="%22PHARMACODYNAMICS%22">PHARMACODYNAMICS</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Simple Summary: Here, we show that the plant-derived product, sanguinarine, inhibited aerobic glycolysis and oxidative phosphorylation; which resulted in energy alternations and necroptosis of tumor cells. Moreover, we identify the PKM2/β-catenin axis as the main target in sanguinarine treatment against HCC development. Backgrounds: Abnormal metabolism is the hallmark of hepatocellular carcinoma. Targeting energy metabolism has become the major focus of cancer therapy. The natural product, sanguinarine, displays remarkable anti-tumor properties by disturbing energy homeostasis; however, the underlying mechanism has not yet been elucidated. Methods: The anticancer activity of sanguinarine was determined using CCK-8 and colony formation assay. Morphological changes of induced cell death were observed under electron microscopy. Necroptosis and apoptosis related markers were detected using western blotting. PKM2 was identified as the target by transcriptome sequencing. Molecular docking assay was used to evaluate the binding affinity of sanguinarine to the PKM2 molecule. Furthermore, Alb-CreERT2; PKM2loxp/loxp; Rosa26RFP mice was used to construct the model of HCC—through the intervention of sanguinarine in vitro and in vivo—to accurately explore the regulation effect of sanguinarine on cancer energy metabolism. Results: Sanguinarine inhibited tumor proliferation, metastasis and induced two modes of cell death. Molecular docking of sanguinarine with PKM2 showed appreciable binding affinity. PKM2 kinase activity and aerobic glycolysis rate declined, and mitochondrial oxidative phosphorylation was inhibited by sanguinarine application; these changes result in energy deficits and lead to necroptosis. Additionally, sanguinarine treatment prevents the translocation of PKM2 into the nucleus and suppresses the interaction of PKM2 with β-catenin; the transcriptional activity of PKM2/β-catenin signaling and its downstream genes were decreased. Conclusions: Sanguinarine showed remarkable anti-HCC activity via regulating energy metabolism by PKM2/β-catenin signaling. On the basis of these investigations, we propose that sanguinarine might be considered as a promising compound for discovery of anti-HCC drugs. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of Cancers is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
PLink | https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=a9h&AN=178701175 |
RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3390/cancers16142533 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 19 StartPage: 2533 Subjects: – SubjectFull: COMPUTER-assisted molecular modeling Type: general – SubjectFull: BIOLOGICAL models Type: general – SubjectFull: FLOW cytometry Type: general – SubjectFull: IN vitro studies Type: general – SubjectFull: TISSUE arrays Type: general – SubjectFull: RESEARCH funding Type: general – SubjectFull: COLONY-forming units assay Type: general – SubjectFull: GLYCOLYSIS Type: general – SubjectFull: PHOSPHORYLATION Type: general – SubjectFull: MITOCHONDRIA Type: general – SubjectFull: T-test (Statistics) Type: general – SubjectFull: DATA analysis Type: general – SubjectFull: HOMEOSTASIS Type: general – SubjectFull: ANTINEOPLASTIC agents Type: general – SubjectFull: ELECTRON microscopy Type: general – SubjectFull: APOPTOSIS Type: general – SubjectFull: CELL proliferation Type: general – SubjectFull: PHYTOCHEMICALS Type: general – SubjectFull: TUMOR markers Type: general – SubjectFull: CYTOSKELETAL proteins Type: general – SubjectFull: CELLULAR signal transduction Type: general – SubjectFull: REVERSE transcriptase polymerase chain reaction Type: general – SubjectFull: DESCRIPTIVE statistics Type: general – SubjectFull: IN vivo studies Type: general – SubjectFull: FLUORESCENT antibody technique Type: general – SubjectFull: ENERGY metabolism Type: general – SubjectFull: CELL lines Type: general – SubjectFull: MICE Type: general – SubjectFull: METASTASIS Type: general – SubjectFull: REACTIVE oxygen species Type: general – SubjectFull: IMMUNOHISTOCHEMISTRY Type: general – SubjectFull: CELL death Type: general – SubjectFull: ANIMAL experimentation Type: general – SubjectFull: WESTERN immunoblotting Type: general – SubjectFull: GENE expression profiling Type: general – SubjectFull: ONE-way analysis of variance Type: general – SubjectFull: STATISTICS Type: general – SubjectFull: MOLECULAR structure Type: general – SubjectFull: STAINS & staining (Microscopy) Type: general – SubjectFull: DATA analysis software Type: general – SubjectFull: HEPATOCELLULAR carcinoma Type: general – SubjectFull: SEQUENCE analysis Type: general – SubjectFull: PRECIPITIN tests Type: general – SubjectFull: PHARMACODYNAMICS Type: general Titles: – TitleFull: Sanguinarine Induces Necroptosis of HCC by Targeting PKM2 Mediated Energy Metabolism. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kong, Rui – PersonEntity: Name: NameFull: Wang, Nan – PersonEntity: Name: NameFull: Zhou, Chunli – PersonEntity: Name: NameFull: Zhou, Yuqing – PersonEntity: Name: NameFull: Guo, Xiaoyan – PersonEntity: Name: NameFull: Wang, Dongyan – PersonEntity: Name: NameFull: Shi, Yihai – PersonEntity: Name: NameFull: Wan, Rong – PersonEntity: Name: NameFull: Zheng, Yuejuan – PersonEntity: Name: NameFull: Lu, Jie IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 07 Text: Jul2024 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 20726694 Numbering: – Type: volume Value: 16 – Type: issue Value: 14 Titles: – TitleFull: Cancers Type: main |
ResultId | 1 |